COMPREHENSIVE MULTIPLATFORM ANALYSIS OF CDKN2A ALTERATIONS IN MENINGIOMAS

por Wang, Justin Z, Patil, Vikas, Liu, Jeff, Dogan, Helin, Tabatabai, Ghazaleh, Behling, Felix, Hoffman, Elgin, Bunda, Severa, Yakubov, Rebecca, Kaloti, Ramneet, Brandner, Sebastian, Gao, Andrew, Gadol, Aaron-Cohen, Barnholtz-Sloan, Jennifer, Skardelly, Marco, Tatagiba, Marcos, Raleigh, David, Sahm, Felix, Boutros, Paul C, Aldape, Kenneth, Nassiri, Farshad, Zadeh, Gelareh
Publicado 2023

Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas

por Wang, Justin Z., Patil, Vikas, Liu, Jeff, Dogan, Helin, Tabatabai, Ghazaleh, Yefet, Leeor S., Behling, Felix, Hoffman, Elgin, Bunda, Severa, Yakubov, Rebecca, Kaloti, Ramneet, Brandner, Sebastian, Gao, Andrew, Cohen-Gadol, Aaron, Barnholtz-Sloan, Jill, Skardelly, Marco, Tatagiba, Marcos, Raleigh, David R., Sahm, Felix, Boutros, Paul C., Aldape, Kenneth, Nassiri, Farshad, Zadeh, Gelareh
Publicado 2023

Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas

por Wang, Justin Z., Patil, Vikas, Liu, Jeff, Dogan, Helin, Tabatabai, Ghazaleh, Yefet, Leeor S., Behling, Felix, Hoffman, Elgin, Bunda, Severa, Yakubov, Rebecca, Kaloti, Ramneet, Brandner, Sebastian, Gao, Andrew, Cohen-Gadol, Aaron, Barnholtz-Sloan, Jill, Skardelly, Marco, Tatagiba, Marcos, Raleigh, David R., Sahm, Felix, Boutros, Paul C., Aldape, Kenneth, Nassiri, Farshad, Zadeh, Gelareh
Publicado 2023